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322Objectives: Little is known about the role of Wnt/b-catenin in postnatal airway homeostasis and basal cell
function. This study aimed to investigate the role of Wnt signaling in the self-renewal of basal cells and the
involvement of b-catenin in tracheal repair after naphthalene-induced injury.
Methods: Mice were treated with naphthalene and injected with 4-hydroxytamoxifen. Injury and repair of the
tracheal epithelium after naphthalene-mediated secretory cell depletion was assessed by a immunohisto-
chemical study. The involvement of Wnt and b-catenin signaling in basal cell proliferation was investigated
during in vitro expansion.
Results: Immunohistochemical analysis of tracheal epithelium in wild-type mice showed a reduction in the
number of Clara cell secretory protein (CCSPþ) and forkhead box transcription factor (Fox-J1þ) cells on
days 2 to 5 after naphthalene-induced injury; this cell population was regenerated by day 10. After flush labeling,
bromodeoxyuridine-positive (BrdUþ) cells and Ki67þ cells were observed in tracheal epithelium on days 2 to 5
but not on days 10 and 21. Confocal microscopy visualizing K5þ and BrdUþ cells showed that Wnt3a promotes
proliferation of K5þ cells. Immunohistochemical analysis of K5þ and CCSPþ in tracheal epithelial cells from
wild-type littermate and K5-Cre–mediated b-catenin knock-out mice showed that on day 3, the number of
CCSPþ cells was decreased in all mice. On day 10, CCSPþ cells were present in wild-type littermate mice
but absent in conditional knock-out mice.
Conclusions: Basal cells serve as stem cells in the tracheal epithelium, regenerating and maintaining tracheal
epithelial cells in a mouse model of tracheal injury. b-Catenin is required for proliferation and self-renewal of
tracheal epithelial cells. (J Thorac Cardiovasc Surg 2014;148:322-32)Mouse tracheal epithelium is pseudostratified and
composed of basal cells, secretory cells (Clara cells), and
ciliated cells. Histologic markers to define tracheal epithe-
lial cell types include keratin (K5, K14) for basal cells,
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The Journal of Thoracic and Cardiovascular Surgforkhead box transcription factor (Fox-J1) for ciliated
cells.1 Basal cells (BCs) are relatively undifferentiated cells
that make up approximately 30% of the pseudostratified
mucociliary epithelium of the lung. BCs are present
throughout the airways of the human lung, including small
bronchioles.2 In rodents, BCs are confined to the trachea,
where they are interspersed among the ciliated, secretory,
and neuroendocrine cells. Although murine tracheal BCs
have been shown to play a role in maintaining homeostasis
in the human lung, the precise mechanism is unknown.3
Using bromodeoxyuridine (BrdU) uptake, Borthwick
and colleagues4 showed that BCs make up 80% of the repli-
cating cells during repair of tracheal epithelial damage
induced by detergent or sulfur dioxide inhalation. Another
study suggests that BCs do not contribute to columnar
cell repopulation during repair but rather form an epithelial
barrier to defend against further insult to the basement
membrane.5 Strong evidence implicates BCs as putative
stem cells in the trachea and main bronchi. These
observations were made in studies using in vivo genetic
lineage labeling of K14þ or K5þBCs and an in vitro clonal
sphere-forming assay in which mouse K5þ BCs self-renew
and generate luminal cells.6
To investigate the role of BCs in repairing airway injury,
several models have been applied. Most of these models are
dependent on the induction of Clara cell injuries by lungery c July 2014
Abbreviations and Acronyms
BC ¼ basal cells
BrdU ¼ bromodeoxyuridine
BSA ¼ bovine serum albumin
CCSP ¼ Clara cell secretory protein
DAPI ¼ 4,6-diamidino-2-phenylindole
DMSO ¼ dimethylsulfoxide
Fox-J1 ¼ forkhead box transcription factor
4-OHT ¼ 4-hydroxytamoxifen
PBS ¼ phosphate-buffered saline
PCNA ¼ proliferating cell nuclear antigen
USG ¼ Ultroser G serum substitute
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cells.7 Cytochrome P450 mixed-function oxidases serve
to metabolize xenobiotics in the lungs and CCSPþ cells
serve to protect the lungs against hyperoxic damage8 and
inflammation.9 Because of the cellular preference and
high levels of expression of cytochrome P450 monooxyge-
nase isoform 2F2 (CYP2F2), CCSPþ cells have been the
subject of numerous investigations to define their regulation
and functional significance. Among the lung toxins
administrated in rodent models, naphthalene is the one
most often used for this purpose, not only because it is a
harmful environmental toxin and can be found in ambient
water, groundwater, and cigarette smoke10 but also because
its toxicity requires metabolic catalyzation by cytochrome
P450 monooxygenases.11 Because mouse Clara cells are
the primary cellular site of CYP2F2 in the airway, murine
Clara cells are more susceptible to naphthalene-induced
injury than other types of airway epithelial cells.12
Wnt signals are transduced in a context-dependent
manner to the canonical Wnt pathway for cell-fate determi-
nation.13 Wnt proteins activate the canonical Wnt pathway
through interaction with their Frizzled family receptors and
LRP5/6 family coreceptors.14 This interaction stabilizes
b-catenin levels and affects the subcellular localization of
b-catenin. Wnt signaling is endogenously activated in un-
differentiated embryonic stem cells and is downregulated
on differentiation. In addition, activation of Wnt signaling
by a pharmacologic GSK-3-specific inhibitor can maintain
pluripotency in human and mouse embryonic stem cells.15
Previous studies also indicate that the self-renewal of
hematopoietic stem cells in vitro can be promoted by acti-
vation of the canonical Wnt signaling pathway.16 FZD2
and FZD6 are expressed on mesenchymal stem cells, in
which Wnt10B activates the canonical Wnt signaling
cascade to inhibit their differentiation into adipocytes.17
The role of Wnt/b-catenin in postnatal airway homeosta-
sis and BC function is unknown. To investigate these
questions, we generated a transgenic mouse line in this
study that allowed us to genetically manipulate K5þ BCsThe Journal of Thoracic and Caand trace their lineage. We also investigated the kinase acti-
vation profile of BCs during in vitro expansion. We have
shown that Wnt signaling plays an important role in the
self-renewal of BCs and that b-catenin is necessary for
in vitro proliferation and in vivo tracheal repair. The study
design included immunohistochemical analysis performed
to evaluate the expression of the markers of tracheal epithe-
lial cell types after naphthalene-induced injury. An in vitro
study was carried out to identify theWnt/b-catenin pathway
as the key signaling pathway necessary for basal cell
proliferation. A confocal immunofluorescence study was
performed to evaluate if there is nuclear translocation
of b-catenin. Using transgenic mice, we investigated if
b-catenin is required for tracheal repair after naphthalene-
induced injury in vivo.MATERIALS AND METHODS
Mice, Transgenic Mice, and Animal Husbandry
Colonies of either wild-type or genetically modified mice were
maintained as in-house breeding colonies under specific pathogen-free
conditions in the Laboratory Animal Facility of Taipei Veterans General
Hospital. Animals received humane care and the protocol was approved
by the Animal Committee of Taipei Veterans General Hospital. Tg(BK5-
CreERT)-inducible (I) mice bearing theBK5-CreERT transgenewere gener-
ated by pronuclear microinjection and further maintained on a C57BL/6J
background. ROSA26 Cre reporter mice (Gt[ROSA]26Sortm1Sor; Jackson
Laboratory, Bar Harbor, Maine) on a C57BL/6:129 mix background
are referred to as R26Rmice in this report. Tg(BK5-CreERT):R26R bigenic
mice were generated by breeding BK5-CreERT mice with ROSA26 Cre
reporter (R26R) mice as described previously.18 B6.129-Ctnnb1tm2Kem/
KnwJ (b-cateninFL) mice were generated as previously described19 and
are available at Jackson Laboratory. BK5-CreERT;b-cateninfloxdel/þ
mice were mated with b-cateninFL/FL mice to generate BK5-
CreERT;b-cateninfloxdel/FL embryos (referred to generally as mutant
embryos). Littermate b-cateninfloxdel/FL mice served as controls. The
genotype was determined by polymerase chain reaction amplification of
genomic DNA prepared from a 1-cm tail biopsy. For genotyping, the
primers and cycling parameters have been described elsewhere.17 For
detecting lacZ, the following primers were used: 50-GCA GAC CGT
TTT CGC TCG G-30 and 50-CGA CCG CAT GGT CAG AAG C-30.
Naphthalene and 4-Hydroxytamoxifen Treatments
Mice aged between 8 and 12 weeks were treated with naphthalene at a
dose of 275 mg/kg body weight. Groups of 4 to 6 mice were allowed to
recover for 0, 2, 3, 5, 10, or 21 days and injected intraperitoneally (i.p.)
with 50 mg/kg body weight of BrdU (Sigma, St Louis, MO) 2 hours before
being killed. Parenteral administration of 4-hydroxytamoxifen (4-OHT;
Sigma) was used for conditional introduction of lineage tags within
Tg(BK5-CreERT):R26R bigenic mice. 4-OHT treatment was used as an
inductive agent in BK5-CreERT transgenic mice to activate the expression
of Cre recombinase. 4-OHT was prepared as a 40 mg/mL suspension in
sunflower seed oil and 100 mL of a 40 mg/mL solution was injected i.p.
each day on days1, 0, and 1 after naphthalene exposure. Groups of naph-
thalene/4-OHTtreated mice were then killed on day 0 and day 45 after
naphthalene exposure for evaluation of LacZ reporter gene expression.
b-Galactosidase Histochemistry
The cell type specificity and ligand-dependence of cre-mediated recom-
bination was assessed for each K5 line using systemic administration of
4-OHT (100 mg/mouse) in sunflower oil (250 mL/mouse i.p.) to therdiovascular Surgery c Volume 148, Number 1 323
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treated with 4-OHT, fixed in 4% paraformaldehyde for 20 minutes at room
temperature, and stored in phosphate-buffered saline (PBS) at 4C. For his-
tochemical detection of Escherichia coli b-galactosidase enzymatic activ-
ity, tissues were incubated in X-gal staining solution (5 mmol/L K3Fe
[CN]3, 5 mmol/L K4Fe[CN]6, 2 mmol/L MgCl2, 0.02% Nonidet P-40,
0.01% sodium deoxycholate, 13 PBS, and 1 mg/mL 5-bromo-4-chloro-
3-indolyl-D-galactopyranoside [X-gal]), for 4 to 5 hours at 37C in the
dark, washed in PBS, and fixed in 4% paraformaldehyde at 4C overnight.
Immunohistochemistry
Adjacent serial sections were rapidly cleared with 3 changes of xylene,
hydrated through graded ethanol solutions (100% to 70%), equilibrated to
water, and quenched with 3% peroxide for 20 minutes. Sections were
blocked with PBS/0.5% bovine serum albumin (BSA) (blocking solution)
for 20 minutes and incubated with rabbit-anti-CCSP (1:1600), rabbit-anti-
K5 (1:1000), mouse IgG2b-anti-Fox-J1 (1:4000), rabbit-anti-BrdU
(1:2000), rabbit-anti-b-catenin (1:500), or blocking solution overnight at
4C. Sections were washed extensively in 13 PBS and incubated with bio-
tinylated goat-anti-rabbit Ig (1:200 in blocking solution) or goat-anti-
mouse IgG2b in blocking buffer for 1 hour at room temperature. Sections
were washed and further incubated with streptavidin-horseradish peroxi-
dase (1:4000) in PBS.
Immunofluorescence
Sections were prepared as indicated earlier. Antigens were retrieved by
equilibrating the sections to 10 mM citrate buffer (pH 6.0), microwaving
for 20 minutes, and passive cooling to 4C. Sections were blocked with
5%BSA/PBS before application of primary antibodies. Primary antibodies
were diluted in 5% BSA/PBS and used at the stated concentrations. Slides
were incubated overnight at 4C, washed, and secondary antibodies applied
for 0.5 hours at room temperature. Slides were coverslipped using
Fluoromount-G containing 2 mg/mL 4,6-diamidino-2-phenylindole
(DAPI; Sigma; St Louis, Mo).
Mouse Tracheal Epithelium Primary Culture
Specific pathogen-free C57BL/6N mice of both sexes, aged 5 to 8
weeks, were used for isolation and culture of tracheal epithelial cells.20
On day 1, the mice were sterilized with 70% ethanol, and the whole tra-
cheas were excised, cut open lengthwise, washed in PBS, and transferred
to collectionmedium prewarmed to 37C. Batches of 8 tracheas were trans-
ferred to 20mL of prewarmed dissociationmedium containing pronase and
DNase and incubated at 37C for 60 minutes, followed by termination of
the enzyme reaction with 5 mL of sterile fetal calf serum. To dissociate
epithelial cells, the tracheas were gently agitated up to 12 times. The
tracheal husks were removed from the suspension, placed in 10 mL of cul-
ture medium, and gently agitated 12 times as before to release more epithe-
lial cells. The resultant cell suspensions were pooled and centrifuged at
200 3 g for 5 minutes at 22C. After the supernatants were removed, the
pellets were resuspended and washed in 10 mL of culture medium, centri-
fuged at 200 3 g for 5 minutes, and resuspended in 5 mL of culture me-
dium. This suspension was incubated at 37C for 2 hours in a 100-mm
culture dish to remove contaminating nonepithelial cells. After incubation,
the medium was removed with a fine-tip flexible pipette to collect the un-
attached cells, centrifuged at 1000 rpm for 5 minutes, and resuspended in
culture medium (200 mL for every 2 tracheas used). The dissociated cells
from 2 tracheas were seeded onto 1 tissue culture insert semipermeable
support membrane (Costar Transwell, tissue culture-treated polyester
membrane 24-well plate inserts, 0.4-mm pore; Corning Inc, Corning,
New York) in 200 mL of culture medium, with 600 mL outside the insert.
To precoat these inserts with type IVacid-soluble human placental collagen
(Sigma-Aldrich, St Louis, Mo), 100 mL of collagen solution (0.5 mg/mL of
human placental collagen in distilled water with 0.2% glacial acetic acid)324 The Journal of Thoracic and Cardiovascular Surgwas added to the membrane, air-dried overnight, and then washed twice
with PBS before use. The cells were maintained at 37C in 21% O2 and
5% CO2 in a humidified incubator for 3 days. On day 4, the medium on
the apical surface of the cultured cells was removed, along with nonadher-
ent cells and debris, and themedium on the outside of the insert (bathing the
basolateral surface) was replaced with 600 mL of Ultroser G medium
(Gibco, Rockville, Md). Once the cells had reached confluence, the apical
surface of the insert appeared dry. The medium was replaced twice weekly.
Crystal Violet Assay
Primary mouse tracheal epithelial cells grew at an air-liquid interface.
These cells were subcultured once and seeded at a density of 1 3 104
cells/well into a 24-transwell plate for 48 hours in Ultroser G serum substi-
tute (USG) medium (Crescent Chemical Company, Islandia, NY) with
either dimethylsulfoxide (DMSO, 20 mM; Sigma), DKK1 (300 ng/mL;
R&D Systems, Minneapolis, Minn), Wnt3a (200 ng/mL; R&D Systems),
LY inhibitor (20 mM; Sigma), ERK inhibitor (20 mM; Sigma), P38 inhibitor
(20 mM; Sigma), JNK inhibitor (20 mM; Sigma), or STAT3 inhibitor (20
mM; Sigma), which was added every 24 hours. The cells were fixed in
methanol and stained with Crystal Violet solution. Cell number was as-
sessed by counting the number of nuclei in 10 fields of each sample at
2003 and 4003 magnification.
In Vitro Cell Proliferation Assay
Primary mouse tracheal epithelial cells were subcultured once and
cultured for 48 hours in USG medium with either DMSO (20 mM),
DKK1 (300 ng/mL), Wnt3a (200 ng/mL), LY inhibitor (20 mM), ERK in-
hibitor (20 mM), P38 inhibitor (20 mM), JNK inhibitor (20 mM), or STAT3
inhibitor (20 mM), which was added every 24 hours. BrdU (10 mm; Sigma)
was added to the medium 24 hours before collecting the cells at the end
point. The cells were fixed in 4% paraformaldehyde and stained with
rabbit-anti-BrdU antibody (1:100; ABBIOTEC, San Diego, Calif) and
rabbit-anti-K5 antibody (1:100; Abcam, Cambridge, Mass).
In Vitro Cell Death Assay
Primary mouse tracheal epithelial cells were subcultured once and
cultured for 48 hours in USG medium with DMSO (20 mM), DKK1 (300
ng/mL), andLYinhibitor (20mM).Apoptosiswas detectedusing the terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay detec-
tion kit (Roche Applied Science, Indianapolis, Ind) on tissue culture insert
semipermeable support membrane. All inserts were mounted with DAPI in
Vectashield mounting medium (Vector Laboratories, Burlingame, Calif).
Statistical Analysis
Three animals were used per experimental group. The experiments
(in vitro) were repeated at least 3 times. The number of the tracheal epithe-
lial cells from the animals used in the study varied after naphthalene-
induced injury. For interpretation of the immunohistochemical staining
results in the study, a minimum of 100 tracheal epithelial cells at random
were measured for each slide (n ¼ 3 per experimental group). The immu-
nohistochemical results were analyzed quantitatively in a blinded manner
by at least 2 separate observers (intraclass correlation coefficient was
0.990, P<.0001). The results are expressed as means standard deviation.
Statistical analysis was performed using Excel software (Microsoft Corpo-
ration, Bellevue, Wash). Differences between the data were tested for sta-
tistical significance using the t test.
RESULTS
Repair of Tracheal Epithelium After
Naphthalene-Induced Clara Cell Injury
In untreated or vehicle-treated (corn oil) mice, examination
of tracheal sections revealed a pseudostratified epithelium inery c July 2014
Hsu et al Evolving Technology/Basic Sciencethe trachea. Naphthalene exposure resulted in sloughing of
most of the tracheal epithelium as was observed on day 2. By
day 3 to day 5, after naphthalene treatment, many areas of tra-
chea had regenerated a hypertrophic epithelium.Onday10 and
day 21, the trachea was restored to a normal pseudostratified
epithelium (Figure 1). CCSPþ cells were numerous within
the tracheas of control mice and were distributed throughout
the epithelium before treatment. Fox-J1þ ciliated cells were
scattered throughout the epithelium. K5þ BCs formed a
continuous layer in the lower part of the pseudostratified
epithelium. Naphthalene treatment of mice resulted in a dra-
matic decrease of CCSPþ cells. By day 2 of recovery, nearly
all Clara cells were exfoliated, a process accompanied by a
marked decrease in the overall epithelial cell density. Similarly,
almost all ciliated cells were exfoliated. In contrast, there was
no noticeable change in the number or distribution of BCs at
this time point. On day 3 of recovery, Clara cells and ciliated
cells were still absent in the epithelium; hyperplastic BCs
were evident, as was an increase in the overall epithelial cell
density. Restoration of a CCSPþ population and reestablish-
ment of pseudostratified epithelium was evident on day 10 of
recovery and was associated with regression of hyperplastic
K5þ cells. The epithelium returned to its normal composition
by day 21 of recovery. No further changes in epithelial
morphology were observed after this time point.
BCs are Multipotent Progenitors of the Tracheal
Epithelium In Vivo
Nearly all CCSPþ cells and Fox-J1þ ciliated cells had
exfoliated by day 2 after naphthalene-mediated tracheal
injury. The cells had not recovered at day 3, when theFIGURE 1. Immunohistochemical analysis of tracheal epithelium after naphthale
animals used in the study varied after naphthalene-induced injury. For interpretat
100 tracheal epithelial cells at random were measured for each slide (n ¼ 3 per e
***P<.005 versus day 0, as determined by the Student t test. Scale: 50 mm. H&E,
box transcription factor.
The Journal of Thoracic and CaK5þBCs became hyperplastic, and were restored to normal
by day 10 to 21. We thus hypothesized that the K5þ BCs
that were hyperplastic on day 3 gave rise to CCSPþ cells
and Fox-J1þ ciliated cells. To test this hypothesis, tracheas
of naphthalene-treated and 4-OHTtreated Tg(BK5-
CreERT):R26R bigenic mice on day 46 of recovery were
examined after whole-mount X-gal staining. On day 46,
groups of b-galþ cells were visible throughout the tracheal
epithelium and varied in size from 5 to 20 cells. b-galþ cells
were usually grouped close together, suggesting clonal
expansion of a tagged cell. Some clusters contained up
to 10 more cells; others appeared to be mixtures of b-gal–
positive and b-galnegative cells (Figure 2, A). These
data indicate that K5-expressing BCs that had been labeled
during 4-OHTadministration had undergone rounds of pro-
liferation and differentiation during epithelial repair, result-
ing in expansion of the b-galþ groups within the
epithelium. The presence of large groups of LacZþ cells
that were uninterrupted by b-galnegative cells suggests
that the initially tagged precursor cell(s) possessed signifi-
cant self-renewal capacity. The phenotype of cells present
in each b-galþ group was determined on day 46 using a
combination of histochemical and immunofluorescence
techniques. Histochemical and morphologic analysis
demonstrated that most of the b-galþ cell clusters harbored
multiple cell types, including BCs and columnar epithelial
cells (Figure 2, A). Immunofluorescence revealed that the
b-galþ clusters included both K5þ basal and K5-negative
nonbasal/columnar cell phenotypes (Figure 2, B), secretory
(CCSP) cells, or ciliated (Fox-J1) markers, confirming that
K5-expressing cells tagged during repair from naphthalene-ne treatment in wild-type mice. The number of tracheal epithelial cells in the
ion of the immunohistochemical staining results in the study, a minimum of
xperimental group). The figures shown are representative images **P<.01;
Hematoxylin and eosin; CCSP, Clara cell secretory protein; Fox-J1, forkhead
rdiovascular Surgery c Volume 148, Number 1 325
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FIGURE 2. Histochemical analysis and immunofluorescence after
administration of 4-hydroxytamoxifen (4-OHT) in Tg(BK5-
CreERT):R26R bigenic mice. A, b-Galactosidase histochemistry; B,
immunofluorescence at 46 days after 4-OHT treatment; C, quantitative
immunofluorescence data. Scale: A, 50 mm; B, 10 mm. DAPI, 4,6-
Diamidino-2-phenylindole; CCSP, Clara cell secretory protein; Fox-J1,
forkhead box transcription factor.
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tracheal epithelium (Figure 2, B and C).Naphthalene Induces Proliferation of BCs on Days
2 to 5
To gain insight into the proliferative status of hyper-
plastic K5þ BCs, animals that had undergone naphthalene
treatment were infused with BrdU 2 days before being
killed. Immunohistochemical staining of tracheal epithe-
lium using specific antibodies against BrdU and Ki67
showed that the BrdUþ and Ki67þ cells were present on
days 2 to 5 after naphthalene treatment, with the maximum
fraction of positive cells (as high as 75%) occurring on day
3 (Figure 3). In samples from days 10 and 21, BrdU and
Ki67 staining was absent. Moreover, double immunofluo-
rescence using antibodies against K5 and BrdU revealed
that the BrdUþ cells were also positive for K5 (Figure 5).
These data suggest that proliferation of hyperplastic K5þ
cells occurred from days 2 to 5 after naphthalene treatment.
Involvement of Wnt Signaling in BC Proliferation
In Vitro
To identify the specific signaling pathway involved in the
self-renewal or proliferation ofBCs, primarymouse tracheal
epithelial cells in an air-fluid interface culture were treated
with specific regulators of a variety of signaling pathways
that are important for proliferation of self-renewal of certain
stem cells, including a specific activator (Wnt3a) and an in-
hibitor (DKK1) ofWnt/b-catenin, and the inhibitor of PI3K/
Akt (LY2940902), MEK/ERK (PD98059), p38MAPK
(SB203580), JNK (SP600125), Stat3 (S3I-201).21,22 We
observed that for cells treated with Wnt3a, the total cell
number (Figure 4,A), the total K5þ cell number, the BrdUþ
ratio, and the BrdUþ ratio of K5þ cells increased compared
with the control, whereas in cells treated with DKK1, these
indices decreased compared with the control (Figure 4, B),
suggesting the involvement of Wnt/b-catenin in the regula-
tion of K5þ BC proliferation or self-renewal. Moreover, we
found that for cells treated with LY294002, the number of
apoptotic cells increased compared with the control
(Figure 4, C), consistent with the role of PI3K/Akt func-
tioning as an important mediator of the antiapoptotic effects
of keratinocyte growth factor.23 These data suggest
Wnt/b-catenin signaling is involved in the proliferation or
self-renewal of K5þ BCs in vitro.
Activation ofWnt/b-Catenin in BCsDuring Repair of
Tracheal Epithelium In Vivo
We then investigated the involvement of Wnt/b-catenin
signaling in the self-renewal and repair of K5þ BCs
in vivo. Compared with the vehicle control, naphthalene
induced an increase in nuclear translocation of b-cateninery c July 2014
FIGURE 3. Immunohistochemical staining of tracheal epithelium with BrdU and Ki67 after naphthalene treatment in wild-type mice. Right panel is the
quantitative data for the left panel. *P<.05, **P<.01, ***P<.005 versus day 0, as determined by the Student t test. Scale: 50 mm. BrdU, Bromodeox-
yuridine.
Hsu et al Evolving Technology/Basic Scienceand BrdU incorporation in K5þ cells on day 3, but not on
day 0 (before naphthalene treatment) or day 10 in wild-
type mice (Figure 5). BrdU incorporation further demon-
strated that cells with an accumulation of b-catenin in
the nuclei were also positive for BrdU on day 3 after naph-
thalene treatment (Figure 5). Moreover, the association of
these proliferative cells with b-catenin accumulation in
the nucleus was not observed on day 0 or day 10 after naph-
thalene treatment (Figure 5). These data suggest that Wnt/
b-catenin signaling is activated in the tracheal epithelium
of mice on day 3 after naphthalene treatment.E
T
/B
SWnt/b-Catenin Signaling Is Required for
Self-Renewal and Repair of BCs
To introduce the b-catenin mutation into tracheal BCs,
we generated mice (BK5-CreERT) that express CreERT un-
der the control of the K5 gene. Exons 2 to 6 were deleted
after crossbreeding for conditional inactivation of the b-cat-
enin gene. Nuclear translocation of b-catenin and BrdU
incorporation were observed in K5þ cells of the wild-
type littermate mice on day 3 after naphthalene treatment
(Figure 6, A and C). As expected, deletion of b-catenin by
4-OHT infusion caused a decrease in nuclear translocation
of b-catenin and BrdU incorporation in K5þ cells in trans-
genic mice (Figure 6, B and C). Immunohistochemical
staining of K5 and CCSP in tracheal epithelial cells from
wild-type littermate and transgenic mice showed that onThe Journal of Thoracic and Caday 3, CCSPþ cells were diminished in both wild-type
and transgenic mice, whereas on day 10, CCSPþ cells
were present in wild-type mice but still absent in transgenic
mice (Figure 6, D).DISCUSSION
This study is the first to demonstrate that b-catenin is
necessary for the proliferation of BCs in vitro and in vivo
during tracheal repair after naphthalene treatment. We
also found that BCs rather than Clara cells were responsible
for tracheal epithelial repair in a mouse model of tracheal
injury. Using an in vitro primary culture of tracheal epithe-
lium, we demonstrated that Wnt3a promotes proliferation
of BCs in vitro. In addition, using a tracheal epithelial repair
model in transgenic mice, we showed that b-catenin is
required for tracheal repair after naphthalene-induced
injury in vivo. It was reported that after naphthalene-
induced tracheal injury in mice, proliferation of Clara cells
was complete within 4 to 14 days after injury.24 In the pre-
sent study, after naphthalene-induced injury, expression of
CCSP was present at 10 days after injury. The expression
of Fox-J1 was abundant at 21 days after injury. According
to previous reports and our findings, we suggested that the
biphasic appearance of Clara cells and ciliated cells is
because that K5þ BCs give rise to Clara cells and then
Clara cells give rise to ciliated cells during tracheal epithe-
lium repair after injury.25rdiovascular Surgery c Volume 148, Number 1 327
FIGURE 4. Primary cell culture of mouse tracheal epithelium. A, Crystal Violet staining; B, immunofluorescence; and C, TUNEL assay of mouse tracheal
epithelial cells after culture in the presence of DMSO (vehicle) and each activator or inhibitor for 6 days. Left panels are quantitative data for the right panels.
*P<.05, **P<.01 versus DMSO, as determined by the Student t test. DKK1, 300 ng/mL; Wnt3a, 200 ng/mL; LY294002 (LY), 20 mM; PD98059 (PD), 20
mM; SB203580 (SB), 20 mM; SP600125 (SP), 20 mM; S3I-201 (S3I), 20 mM. Scale: A, 50 mm; B and C, 10 mm. DMSO, Dimethylsulfoxide; BrdU,
bromodeoxyuridine; DAPI, 4,6-diamidino-2-phenylindole.
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FIGURE 5. Immunofluorescence of tracheal epithelium after naphthalene treatment in wild-type mice. Scale: 10 mm. BrdU, Bromodeoxyuridine; DAPI,
4,6-diamidino-2-phenylindole.
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FIGURE 6. Immunofluorescence and immunohistochemical analysis of tracheal epithelium after naphthalene treatment and 4-hydroxytamoxifen (4-OHT)
administration in wild-type littermate mice and BK5-CreERT;b-cateninfloxdel/þ mice. A and B, Immunofluorescence of tracheal epithelium after 3 days of
naphthalene treatment and 4-OHT administration in littermate (A) and transgenic (B) mice. C, Quantitative immunofluorescence data. D, Immunohisto-
chemical analysis of tracheal epithelium after naphthalene treatment and 4-OHT administration. Right panel: quantitative data. *P< .05, **P< .01,
***P<.005 versus transgenic, as determined by the Student t test. Scale: A and B, 10 mm; D, 50 mm.
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naphthalene administration with the peak on day 3. The
K5þ percentage then returned to the level before naphtha-
lene administration. The reason that the K5þ percentage
decreased at day 10 was due to the differentiation of most
of the replicated cells into CCSPþ cells for the restoration
of normal airway epithelium. As indicated previously, BCs
are typically considered to be K5/K14 dual-positive cells.26
The expression of K14 and the role of K14þ cells in trachea
regeneration after naphthalene injury have been well inves-
tigated previously.1,27 Lineage tracing studies revealed that
naphthalene injury upregulates K14 expression and the
expression of K14 peaked between 3 and 6 days after
naphthalene injury, and K14þ BCs gave rise to Clara-like
and ciliated cells. However, the role of K5þ BCs in repair-
ing trachea epithelium after naphthalene injury has not been
well studied. To remedy this situation, we traced the lineage
of K5þ BCs and determined their self-renewal and differ-
entiation potential in repairing epithelium, and elucidated
the involvement of the b-catenin pathway. Thus, the aim
of the current study was to investigate the role of K5þ cells
in trachea regeneration after naphthalene damage. Because
the previous investigation showed that K14þ cells appeared
3 to 6 days after trachea naphthalene damage, we did not
repeat these studies.1,27
Detection of proliferating cells in tissue sections can be
achieved by analysis of BrdU, Ki67, and proliferating cell
nuclear antigen (PCNA) immunohistochemical staining.
According to Muskhelishvilli and colleagues,28 the
numbers of cells expressing these 3 proteins were different
(PCNAþ>Ki67þ>BrdUþ); the data are consistent with
the results of the current study. In our study, we found that in
K5þ cells, the expression of Ki67 was more evident than
BrdU on day 2 to 5, with the number of Ki67þ cells greater
than that of BrdUþ cells. With regard to why it takes 21
days for the full recovery of bronchial epithelium, we
considered that it was because proliferating K5þ cells
give rise to CCSPþ cells and then CCSPþ cells give rise
to Fox-J1þ cells during tracheal epithelium repair after
injury.
Many investigations have addressed the question of
which components of the tracheal epithelium are putative
stem cells, capable of multipotent or unipotent differentia-
tion. In 2004, Hong and colleagues27 noted that BCs have
the capacity to restore fully differentiated epithelium of
the trachea. In 2009, Rock and colleagues29 demonstrated
that the BCs in mouse airways can self-renew and differen-
tiate in the absence of stroma and columnar epithelial cells.
They concluded that BCs in the mouse trachea function as
progenitor cells during postnatal growth and in the adult.
Recently, Ghosh and colleagues1 reported that the tracheal
BC is a tissue-specific stem cell that can generate its own
niche in vitro and participate in tracheal epithelial homeo-
stasis and repair. However, Giangreco and colleagues30The Journal of Thoracic and Careported that a CCSP-expressing stem cell population in ter-
minal bronchioles can function as a regiospecific stem cell
niche to maintain epithelial diversity after injury.
The molecular mechanisms underlying the multipotency
of cells in the tracheal epithelium have not been fully eluci-
dated. Zemke and colleagues31 used transgenic and cell
type–specific knock-out strategies to determine the role of
b-catenin in the normal maintenance and repair of bronchi-
olar epithelium. They showed that functional knock-out of
b-catenin had no impact on the expression of Clara cell dif-
ferentiation markers in airways. They thus concluded that
b-catenin was not necessary for the maintenance or efficient
repair of the bronchiolar epithelium. In the present study,
we found that BCs, rather than Clara cells, function as pro-
genitor cells in the repair of tracheal injury requiring
b-catenin.
Wnt signaling plays a key role in lung development and is
involved in the stem cell signaling pathway and carcinogen-
esis.32 In this pathway, b-catenin acts as a critical transcrip-
tional mediator. Inactivation of b-catenin leads to aberrant
epithelial branching and proximal-distal patterning. In
2003, Mucenski and colleagues33 suggested that b-catenin
may determine the fate of stem cells in the developing
lung. They found that b-catenin expression in distal epithe-
lial cells is required for a subset of progenitor cells to differ-
entiate into peripheral cell types. Harris-Johnson and
colleagues34 showed that inactivation of b-catenin in the
ventral foregut endoderm results in the absence of both
the trachea and lungs. They concluded that b-catenin is
not required for cell survival or proliferation, but rather is
essential for maintaining the respiratory fate. Recently,
Giangreco and colleagues35 demonstrated that b-catenin
can determine the fate of airway BCs and that abnormal
expression of b-catenin is associated with the development
of lung cancer in humans. Smith and colleagues36 also
noted that b-catenin is a critical determinant of in vitro
facultative basal progenitor cell differentiation and that dys-
regulation of the b-catenin signaling pathway may be
involved in disease pathogenesis. In this study, we further
confirmed that Wnt3a/b-catenin enhanced proliferation of
tracheal epithelial cells, both in vivo and after
naphthalene-induced tracheal injury. Thus, BCs act as pro-
genitor cells and are important in the repair and mainte-
nance of tracheal epithelium.
There are several limitations of the current study that
need to be improved in future studies. First, the in vitro cul-
ture assay that screened the important signaling pathways
involved in stem cell regulation did not include all of the
signaling pathways. This could be solved by improving
the primary culture system to expand more BCs for studies.
For example, an abundant cell source could be used for
screening other signaling pathways. These cells could also
be used for assays that require a large number of cells,
such as flow cytometry for analyzing the cell cycle andrdiovascular Surgery c Volume 148, Number 1 331
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ond, the relationship between K5þ BCs and K14þ BCs
during naphthalene-induced airway injury should be eluci-
dated in future studies. Third, upstream and downstream of
the Wnt/b-catenin pathway involved in naphthalene-
induced airway injury should be further clarified using
transgenic approaches.
In conclusion, identification of tracheal epithelial pro-
genitor cells with self-renewal and proliferation capacity
is crucial for elucidating the mechanism of tracheal repair
after injury. From the results of this study, we conclude
that BCs serve as stem cells, regenerating and maintaining
the tracheal epithelium in a mouse model of tracheal injury.
In addition, b-catenin is required for the proliferation of
tracheal epithelial cells. These findings may increase our
understanding of the mechanisms involved in airway repair.
The authors thank Hui-Chen Lee from Biostatistics Task Force,
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